Skip to Main Content

Author Details

Paul J McLaren
2004
81
33
PMIDPaper TitleJournal TitlePublished Year
37532928Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
37670157Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
37747237Host genetic variation at a locus near CHD1L impacts HIV sequence diversity in a South African population.2023
37986808Transcriptomics and chromatin accessibility in multiple African population samples.bioRxiv2023
37261336Cytokine/chemokine profiles in people with recent infection by .2023
37534725A new look at human leukocyte antigen variation in HIV; functional clustering to enhance power for discovery of host genetic associations.2023
35688805Expansion of cytotoxic tissue-resident CD8 T cells and CCR6CD161 CD4 T cells in the nasal mucosa following mRNA COVID-19 vaccination.Nature Communications2022
36179551Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens.EBioMedicine2022
36170228Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.PLoS ONE2022
34611364A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.Nat Genet2021
33489013Dissemination of <i>Mycobacterium tuberculosis</i> is associated to a <i>SIGLEC1</i> null variant that limits antigen exchange via trafficking extracellular vesicles.J Extracell Vesicles2021
34168330HIV-1 and human genetic variation.Nat Rev Genet2021
33534201Rectal microbiota diversity in Kenyan MSM is inversely associated with frequency of receptive anal sex, independent of HIV status.AIDS2021
33173934Increased CHIP Prevalence Amongst People Living with HIV.medRxiv2020
32433252Sex Work Is Associated With Increased Vaginal Microbiome Diversity in Young Women From Mombasa, Kenya.Journal of acquired immune deficiency syndromes (1999)2020
32409920Minding the gap in HIV host genetics: opportunities and challenges.Human Genetics2020
31651980HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.Mol Biol Evol2020
30602460HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control.Proc Natl Acad Sci U S A2019
30728828Interaction of the Host and Viral Genome and Their Influence on HIV Disease.Frontiers in Genetics2018
29331453Are privacy-enhancing technologies for genomic data ready for the clinic? A survey of medical experts of the Swiss HIV Cohort Study.J Biomed Inform2018
28084001No Evidence for Association of β-Defensin Genomic Copy Number with HIV Susceptibility, HIV Load during Clinical Latency, or Progression to AIDS.Ann Hum Genet2017
28845244A39â¿¿Human exome sequencing to evaluate the impact of rare coding variation on HIV-1 control.Virus Evol2017
28716935Severe viral respiratory infections in children with <i>IFIH1</i> loss-of-function mutations.Proc Natl Acad Sci U S A2017
28968755Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.J Infect Dis2017
29209326Retroviruses As Myeloid Cell Riders: What Natural Human Siglec-1 "Knockouts" Tell Us About Pathogenesis.Front Immunol2017
28012378Systemic inflammation before and after antiretroviral therapy initiation as a predictor of immune response among HIV-infected individuals in Manitoba.Cytokine2017
28182649Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.PLoS Comput Biol2017
28041642A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.Am J Hum Genet2017
27790221Corrigendum: Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired <i>Pseudomonas aeruginosa</i> Sepsis.Front Immunol2016
27088321Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.AIDS2016
26996307Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity.Cell Host Microbe2016
26765343Privacy-preserving genomic testing in the clinic: a model using HIV treatment.Genet Med2016
27703454Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired <i>Pseudomonas aeruginosa</i> Sepsis.Front Immunol2016
27510803Identification of Siglec-1 null individuals infected with HIV-1.Nat Commun2016
25032819Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry.Antivir Ther2015
25461247Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.Pharmacogenet Genomics2015
25522017Human genetic variation in HIV disease: beyond genome-wide association studies.Curr Opin HIV AIDS2015
26553974Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.Proc Natl Acad Sci U S A2015
26642228The Characteristics of Heterozygous Protein Truncating Variants in the Human Genome.PLoS Comput Biol2015
25988890The impact of host genetic variation on infection with HIV-1.Nat Immunol2015
26456283Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses.Am J Hum Genet2015
25980612Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses.Retrovirology2015
24996883Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.Gut2015
25226169Disentangling human tolerance and resistance against HIV.PLoS Biol2014
25282103Defining the role of common variation in the genomic and biological architecture of adult human height.Nat Genet2014
25490090A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.PLoS One2014
25734091Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.Open Forum Infect Dis2014
24428872GuavaH: a compendium of host genomic data in HIV biology and disease.Retrovirology2014
25033082HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1.PLoS Pathog2014
24719475HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.J Infect Dis2014
  • 1 - 50 of 81

Recommended Authors

Collaborators

Ecole Polytechnique Federale de Lausanne
Co-authored papers 35
Vir Biotechnology Inc.
Co-authored papers 24
Vanderbilt University Medical Center
Co-authored papers 16
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 15
Vertex Pharmaceuticals
Co-authored papers 13
Ragon Institute of Mass General
Co-authored papers 9
Northwestern University Feinberg School of Medicine
Co-authored papers 8
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 5
Co-authored papers 5
Institute for Genomic Medicine, Columbia University Irving Medical Center
Co-authored papers 5
Lausanne University Hospital, University of Lausanne
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Center for Systems Genomics, Pennsylvania State University, University Park
Co-authored papers 4
Co-authored papers 4
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers 4
Co-authored papers 4
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
and Children's Research Center, University Children's Hospital Zurich
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3